(Q53562364)

15 May 2018

title

Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma. (English)

1 reference

15 May 2018

1 reference

Jasminka Pavelić

1

1 reference

15 May 2018

Branko Radaković

series ordinal

2

1 reference

15 May 2018

Kresimir Pavelić

series ordinal

3

1 reference

15 May 2018

language of work or name

English

0 references

publication date

30 March 2007

1 reference

15 May 2018

published in

Gynecologic Oncology

1 reference

15 May 2018

volume

105

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

727-735

1 reference

15 May 2018

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The role of the IGF system in cancer growth and metastasis: overview and recent insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The role of insulin-like growth factor 2 and its receptors in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The insulin-like growth factor system and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Insulin-like growth factor family and combined antisense approach in therapy of lung carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Gastric cancer: the role of insulin‐like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6‐P/IGF 2R)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Improving the polymorphism content of the 3' UTR of the human IGF2R gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The consequences of insulin-like growth factors/receptors dysfunction in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

M6P/IGF2R is mutated in squamous cell carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Genomic structure of the human M6P/IGF2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Insulin-like growth factor II in gynecological cancers: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The expression and role of insulin-like growth factor II in malignant hemangiopericytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Endometrial cancer and the IGF system: a case-control study in Greece.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

The insulin like growth factor-1 receptor (IGF-1R) as a drug target: novel approaches to cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Involvement of IGF-II in human cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Loss of IGF-II imprinting in endometrial tumors: overexpression in carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Tumour suppressor genes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

Alteration in pancreatic immunoreactivity of insulin-like growth factor (IGF)-binding protein (IGFBP)-6 and in intracellular degradation of IGFBP-3 in fibroblasts of IGF-II receptor/IGF-II-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.02.012

10.1016/J.YGYNO.2007.02.012

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

17399767

1 reference

15 May 2018